US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Yowie Group Ltd (PK) (YWGRF) 銘柄情報

Yowie Group Ltd (PK) (YWGRF)

0.01

0.00

( 0.00% )

更新日時： 09:00:00

Yowie Group Ltd (PK) (YWGRF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.01

( - )

買値

0.01

売値

0.01

出来高

-

0.00 日の範囲 0.00

0.01 52 週間の範囲 0.01

時価総額

前日終値

0.01

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 0

発行済株式数

263,773,086

配当利回り

PER

-

1 株当たり利益 (EPS)

-0.03

歳入

12.01M

純利益

-7.87M

Yowie Group Limited manufactures and sells of chocolate and confectionery products in Australia, New Zealand, and the United States. It offers surprise inside egg, multi-pack, and series chocolates products. The company is involved in the brand licensing activities. It offers its products under the ... Yowie Group Limited manufactures and sells of chocolate and confectionery products in Australia, New Zealand, and the United States. It offers surprise inside egg, multi-pack, and series chocolates products. The company is involved in the brand licensing activities. It offers its products under the Yowie, BBC, NBA, Bluey, NRL, AFL, and Ernest Hillier brand names. Yowie Group Limited is based in Coburg North, Australia. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Foods

ウェブサイト

yowie.com

本社

Coburg North, Australia

設立

-

Yowie Group Ltd (PK) is listed in the Consumer Staples sector of the その他OTC with ticker YWGRF. The last closing price for Yowie (PK) was US$0.01. Over the last year, Yowie (PK) shares have traded in a share price range of US$ 0.01 to US$ 0.01.

Yowie (PK) currently has 263,773,086 shares in issue. The market capitalisation of Yowie (PK) is US$2.64 million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.01	0.01	0.01	0	0	CS
26	0	0	0.01	0.01	0.01	0	0	CS
52	0	0	0.01	0.01	0.01	0	0	CS
156	0	0	0.01	0.01	0.01	695	0.01	CS
260	-0.015	-60	0.025	0.025	0.01	799	0.01435936	CS

YWGRF - Frequently Asked Questions (FAQ)

What is the current Yowie Group Ltd (PK) share price?

The current share price of Yowie Group Ltd (PK) is US$ 0.01

How many Yowie Group Ltd (PK) shares are in issue?

Yowie Group Ltd (PK) has 263,773,086 shares in issue

What is the market cap of Yowie Group Ltd (PK)?

The market capitalisation of Yowie Group Ltd (PK) is USD 2.64M

What is the 1 year trading range for Yowie Group Ltd (PK) share price?

Yowie Group Ltd (PK) has traded in the range of US$ 0.01 to US$ 0.01 during the past year

What is the registered address of Yowie Group Ltd (PK)?

The registered address for Yowie Group Ltd (PK) is 113-115 Bakers Road, Coburg North, Victoria, 3058

What is the Yowie Group Ltd (PK) website address?

The website address for Yowie Group Ltd (PK) is yowie.com

Which industry sector does Yowie Group Ltd (PK) operate in?

Yowie Group Ltd (PK) operates in the Consumer Products - Foods sector

BBANBOB

BBANBOB 5分前

GENERALLY TAKE 2 TO 3 DAYS FOR NEWS TO DIGEST BEFORE FOLKS REACT.

The Truth Hurts

The Truth Hurts 5分前

Assuming that would occur of course.

AngeloFoca

AngeloFoca 6分前

Do you think the PSM data was developed to support an appeal of a CHM Letter issued after the November 2025 CHM meeting?
Again with this "CHM Letter" THAT WAS NEVER ISSUED!!!

.

stevhoff

stevhoff 6分前

That's right and that's a lot of dilution when the conversion occurs. On a di;luted per share basis, there's nothing there.

MarauderWarlock33

MarauderWarlock33 7分前

https://www.gov.uk/government/news/nhs-patients-get-faster-access-to-medicines-under-new-pilots

NICE updates.

waterpro42

waterpro42 7分前

Ok me and a Canadian buddy just slapped us to 1 MM, somebody else take the baton.

DrHigh

3 million shares traded after great news and we are red. lets see what our OS does later this week. There has been a consistent delay to OS being updated. I bet more than half of today's shares comes from dilution

Jack_Herer

Jack_Herer 7分前

We will release the results when we’re permitted to do so.

Around 4 beers past beer o’clock here in Accra. But I’m celebrating, so give me a break!

brooktrail1933

brooktrail1933 7分前

I'm not sure I agree with your analysis.
The first reason is the flurry of activity on the part of NWBO right after the November CHM meeting, at which we know the MAA was discussed. That's not the sort of thing a company would do if it knew it would be another year before their treatment wou

betman

400,000 at .0001 . Did we just come off the expert market ?

reachjo

reachjo 8分前

underpar71

underpar71 9分前

And, in the midst of all the bickering of blindfolded shareholders, the stock will go red again today.

The Truth Hurts

The Truth Hurts 9分前

Yes, those are from each acquisition and are "insider" control shares. No?

JJ24

Would be nice to see some volume before update . It’s gotta be something super juicy to get a group to buy .

z-money

z-money 10分前

I being impatient, I know. But I wish they would get their act together already. LOL.

SDCRBS

SDCRBS 10分前

⭐ Executive Summary: Melvin Ejiogu (CEO, VeeMost Technologies)
🎓 Education & Credentials
Melvin holds a Bachelor’s degree in Business Administration (Corporate Finance) from the University of Akron in Ohio .

He also holds top-level IT certifications, including th

stevhoff

stevhoff 11分前

Series E preferred:3,898,500. Each share convertibl;e into 1000 shares of common.

US Market News

US Market News 11分前

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
Business Wire TEPKINLY® (epcori

US Market News

US Market News 11分前

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

US Market News

US Market News 11分前

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular LymphomaJuly 6, 2026 1:45 PM
PR Newswire (US) TEPKINLY

nathanial

nathanial 11分前

Number 1 on the breakout boards.

US Market News

US Market News 11分前

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTSJuly 6, 2026 1:50 PM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"July 6, 2026 /PRNewswire/ --

rmoss

Hell he could be just trying to keep his atm open lol

Aquahoya

Aquahoya 12分前

One more MM. Cant be much

Myth

"Blacktop Horizon" Justin Johnson live

https://www.youtube.com/watch?v=uElBgnt45RA

Vertex Pharmaceuticals

Vinco Ventures (EM)

Becton Dickinson &

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。